Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Valentina Hoyos"'
Publikováno v:
Derecho Penal y Criminología, Vol 43, Iss 114 (2022)
El soft law es una fuente del derecho internacional que influye en el derecho penal internacional y en el sistema penal colombiano. La evolución del derecho internacional amplió el alcance y las ventajas de las herramientas del derecho blando, dán
Externí odkaz:
https://doaj.org/article/8bbb9191f2b4456faaaba60f0e0cd2f3
Autor:
Jason A. Mouabbi, Momal Chand, Ishaq A. Asghar, Ramen Sakhi, Daniel Ockner, Carrie L. Dul, Tarik Hadid, Amr Aref, Mothaffar F. Rimawi, Valentina Hoyos
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4790-4795 (2021)
Abstract Objective The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC) and triple‐negative breast cancer (TNBC) in relation to the amount of strom
Externí odkaz:
https://doaj.org/article/c6a62fe8c1c74ba0a71fb27937d91dca
Autor:
Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catherine Robertson, Claudette Foreman, Tao Wang, Shaun Bulsara, Natalia Lapteva, Bambi Grilley, Matthew Ellis, Charles Kent Osborne, Angela Coscio, Julie Nangia, Helen E. Heslop, Cliona M. Rooney, Juan F. Vera, Premal Lulla, Mothaffar Rimawi, Ann M. Leen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Purpose: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic therapeutic approach for patients with breast cancer (BC). In this first-in-human trial, we investigate
Externí odkaz:
https://doaj.org/article/d2a1cea135ca47b2969fd4c6813e68ff
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
To redirect T cells against tumor cells, T cells can be engineered ex vivo to express cancer-antigen specific T cell receptors (TCRs), generating products known as TCR-engineered T cells (TCR T). Unlike chimeric antigen receptors (CARs), TCRs recogni
Externí odkaz:
https://doaj.org/article/7ac04034e68b4662ad09d44f12015278
Autor:
Robin Parihar, Stephen Gottschalk, Ann Leen, Pradip Bajgain, Norihiro Watanabe, Valentina Hoyos, Mary K McKenna, Lauren Kelly, Paul Shafer, Saisha A Nalawade, Arushana Ali, Jarrett Joubert, Juan Fernando Vera Valdes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/dfbeb4bf866d41e59ad5cc0c77aedfd1
Autor:
Malcolm K Brenner, Valentina Hoyos, Ignazio Caruana, Gerrit Weber, Claudia Manuela Arnone, Vinicia Assunta Polito, Angela Mastronuzzi, Andrea Carai, Francesca Camassei Diomedi, Laura Antonucci, Maria Vinci, Francesco Ferrari, Elisa Salviato, Marco Scarsella, Cristiano De Stefanis, Lucia Lisa Petrilli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Pediatric high-grade gliomas (pHGGs) are among the most common and incurable malignant neoplasms of childhood. Despite aggressive, multimodal treatment, the outcome of children with high-grade gliomas has not significantly improved over th
Externí odkaz:
https://doaj.org/article/92dca105104a4c0ab4b5ec8234f913f1
Autor:
Nicole Higashiyama, Julie Nangia, Maryam Nemati Shafaee, Nan Chen, Binu Liz Michael, Mothaffar Rimawi, Valentina Hoyos
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 2, Iss , Pp 100034- (2020)
Trastuzumab deruxtecan has been shown to have responses in heavily pretreated patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. However, the safety of this medication in patients with severe liver dysfun
Externí odkaz:
https://doaj.org/article/b5ad9442d21e4a74a93f4dc5a74c051d
Autor:
Pradip Bajgain, Supannikar Tawinwung, Lindsey D’Elia, Sujita Sukumaran, Norihiro Watanabe, Valentina Hoyos, Premal Lulla, Malcolm K. Brenner, Ann M. Leen, Juan F. Vera
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-13 (2018)
Abstract Background The adoptive transfer of T cells redirected to tumor via chimeric antigen receptors (CARs) has produced clinical benefits for the treatment of hematologic diseases. To extend this approach to breast cancer, we generated CAR T cell
Externí odkaz:
https://doaj.org/article/3a974511d20442b0828fdb9eedbdda9b
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1863 (2021)
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now widely applied across numerous malignancies. Pembrolizumab has two breast-specific indications in triple-negative disease. Currently, programmed death ligand-1 (P
Externí odkaz:
https://doaj.org/article/e6b336766d9f4340899d39d5db846adb
Publikováno v:
Vitae, Vol 21, Iss 2, Pp 107-113 (2014)
Antecedentes: Los efectos cardiovasculares y respiratorios de los agonistas adrenérgicos empleados en patologías como la Enfermedad Pulmonar Obstructiva Crónica (EPOC) y de los β-bloqueantes usados en el glaucoma, generan antagonismo competitivo
Externí odkaz:
https://doaj.org/article/cb00acc31a7941a6afe1cf2db1a0d439